Patent · US Active

Neuroprotective peptide

US10660934B2 · kind B2 · utility

0Cited by

0References

3Claims

0Family size

Assignee

SENJU PHARMACEUTICAL CO., LTD. · JP

Inventors

Takeshi Nakajima · Tokyo, JP
Mamiko Machida · Osaka, JP
Yujiro Hayashi · Tokyo, JP

Key dates

Filing date	Mar 30, 2017
Grant date	May 26, 2020
Priority date	—
Expiry date	Mar 30, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N15/09
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A peptide which has a neuroprotective action, a neuroprotective drug and neuropathic treatment containing the peptide, and a preventive or alleviative pharmaceutical composition. The peptide comprises proline-rich protein 4 having the sequence of SEQ ID NO:1 or a partial sequence thereof, or a modified sequence thereof, which has a neuroprotective action.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.